Investors Sell CME Group (CME) on Strength (CME)
Traders sold shares of CME Group Inc (NASDAQ:CME) on strength during trading hours on Thursday. $115.28 million flowed into the stock on the tick-up and $171.02 million flowed out of the stock on the tick-down, for a money net flow of $55.74 million out of the stock. Of all companies tracked, CME Group had the 0th highest net out-flow for the day. CME Group traded up $0.82 for the day and closed at $189.02
Several brokerages recently issued reports on CME. Berenberg Bank set a $184.00 price objective on CME Group and gave the stock a “hold” rating in a report on Thursday, September 20th. Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a report on Tuesday, September 18th. Citigroup began coverage on CME Group in a report on Tuesday, November 20th. They set a “buy” rating and a $220.00 price objective for the company. Wells Fargo & Co lifted their price objective on CME Group from $175.00 to $177.00 and gave the stock a “market perform” rating in a report on Friday, October 26th. Finally, Deutsche Bank reaffirmed a “buy” rating and set a $192.00 price objective (up from $185.00) on shares of CME Group in a report on Thursday, October 11th. Six research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $194.13.
The firm has a market capitalization of $64.24 billion, a price-to-earnings ratio of 39.23, a price-to-earnings-growth ratio of 2.19 and a beta of 0.46. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.09 and a quick ratio of 1.09.
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 27th. Stockholders of record on Monday, December 10th will be issued a $0.70 dividend. The ex-dividend date is Friday, December 7th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.50%. CME Group’s dividend payout ratio (DPR) is 58.70%.
In other news, Chairman Terrence A. Duffy sold 10,000 shares of the business’s stock in a transaction on Friday, November 23rd. The stock was sold at an average price of $188.80, for a total value of $1,888,000.00. Following the completion of the transaction, the chairman now directly owns 95,652 shares of the company’s stock, valued at $18,059,097.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Julie Winkler sold 5,847 shares of the business’s stock in a transaction on Friday, November 16th. The stock was sold at an average price of $195.01, for a total value of $1,140,223.47. Following the completion of the transaction, the insider now directly owns 24,255 shares of the company’s stock, valued at $4,729,967.55. The disclosure for this sale can be found here. Over the last three months, insiders sold 29,800 shares of company stock valued at $5,628,462. Insiders own 0.43% of the company’s stock.
Several large investors have recently made changes to their positions in CME. Cornerstone Wealth Management LLC purchased a new stake in shares of CME Group in the second quarter valued at $153,000. Dupont Capital Management Corp grew its position in shares of CME Group by 30.5% in the second quarter. Dupont Capital Management Corp now owns 3,326 shares of the financial services provider’s stock valued at $545,000 after purchasing an additional 777 shares during the period. First Trust Advisors LP grew its position in shares of CME Group by 140.9% in the second quarter. First Trust Advisors LP now owns 278,048 shares of the financial services provider’s stock valued at $45,578,000 after purchasing an additional 162,604 shares during the period. Jennison Associates LLC purchased a new stake in shares of CME Group in the second quarter valued at $1,058,000. Finally, Alps Advisors Inc. purchased a new stake in shares of CME Group in the second quarter valued at $1,640,000. 85.89% of the stock is owned by institutional investors and hedge funds.
About CME Group (NASDAQ:CME)
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Featured Article: Balanced Fund
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.